Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder.

Alene Kennedy-HendricksCameron J SchillingAlisa B BuschElizabeth A StuartHaiden A HuskampMark K MeiselbachColleen L BarryMatthew D Eisenberg

Published in: Journal of general internal medicine (2021)

HDHPs do not reduce continuity of buprenorphine treatment among commercially insured enrollees with OUD but may increase financial burden for this population.

Keyphrases

healthcare
public health
mental health
combination therapy
risk assessment
health insurance
climate change